A drug with the SMILES CC(=O)Nc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2-n2ccc(=NC(=O)c3ccc(F)cc3)cc2)cc1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -8.394%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CC(=O)Nc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2-n2ccc(=NC(=O)c3ccc(F)cc3)cc2)cc1
CC(=O)Nc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2-n2ccc(=NC(=O)c3ccc(F)cc3)cc2)cc1
N-[1-[3-[(4-acetamidophenyl)sulfonylamino]quinoxalin-2-yl]pyridin-4-ylidene]-4-fluorobenzamide